Skip to main content

Table 2 Pathogenicity prediction of variants using bioinformatics tool

From: Identification of potential susceptibility genes in patients with primary Sjögren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing

Gene

Transcript

Variant position

Nucleotide change

Amino acid change

Mutation frequency

Polyphen2

MutationTaster

M-CAP

Pathogenicity (ACMG)

Evidence (ACMG)

Phenotypic effect of variant

Reference

FLG

NM_002016.1

Exon 3

c.12064A > T

p.Lys4022Ter

0.0049

/

Disease causing

Likely benign

Moderate pathogenicity

PM2, PP5

Ichthyosis vulgaris

[23, 24]

BCR

NM_004327.3

Exon 19

c.3275_3278dupCCGG

p.Val1094ArgfsTer17

/

/

Disease causing

/

Moderate pathogenicity

PM2, PP5

/

/

GIGYF2

NM_001103146.1

Exon 29

c.3463C > A

p.Pro1155Thr

0.0000

Probably damaging, 1.000

Polymorphism

/

Supporting benign

BP4, BP6

Early-onset Parkinson disease

[25]

ITK

NM_005546.3

Exon 16

c.1741C > T

p.Arg581Trp

0.0005

Probably damaging, 1.000

Disease causing

/

Moderate pathogenicity

PM2, PP5

Autoinflammatory syndrome; lymphoproliferative syndrome 1

[26, 27]

SLC26A4

NM_000441.1

Intron 7

c.919-2A > G

/

0.0000

/

Disease causing

Possibly pathogenic

Moderate pathogenicity

PP5

/

/